Back
LivaNova PLC 10K Form
Buy
64
LIVN
LivaNova PLC
Last Price:
$47.50
Seasonality Move:
8.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-01 | 10Q | LIVN/LivaNova PLC Quarterly |
2023-07-26 | 10Q | LIVN/LivaNova PLC Quarterly |
2023-05-03 | 10Q | LIVN/LivaNova PLC Quarterly |
2022-11-02 | 10Q | LIVN/LivaNova PLC Quarterly |
2022-08-03 | 10Q | LIVN/LivaNova PLC Quarterly |
2022-05-04 | 10Q | LIVN/LivaNova PLC Quarterly |
Receive LIVN News And Ratings
See the #1 stock for the next 7 days that we like better than LIVN
LIVN Financial Statistics
Sales & Book Value
Annual Sales: | $1.3B |
---|---|
Cash Flow: | $13.2M |
Price / Cash Flow: | 17.36 |
Annual Sales: | $18.97 |
Price / Book: | 2.44 |
Profitability
EPS (TTM): | -4.09000 |
---|---|
Net Income (TTM): | $-222.1M |
Gross Margin: | $870.9M |
Return on Equity: | -18.12% |
Return on Assets: | -8.89% |
LivaNova PLC Earnings Forecast
Key LivaNova PLC Financial Ratios
-
The Gross Profit Margin over the past 32 years for LIVN is 69.48%.
-
The Selling, General & Administrative Expenses for LIVN have been equal to 41.99% of Gross Profit Margin.
-
The Research & Development expenses have been 14.56% of Revenue.
-
The Interest Expense is 99.74% of Operating Income.
-
The Net Earning history of LIVN is 5.04% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 19 years.
LivaNova PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | LIVN |
CUSIP: | G5509L |
Website: | livanova.com |
Debt
Debt-to-Equity Ratio: | 0.61 |
---|---|
Current Ratio: | 1.58 |
Quick Ratio: | 1.31 |
Price-to-Earnings
Trailing P/E Ratio: | 39.91 |
---|---|
Forward P/E Ratio: | 11.75 |
LIVN Technical Analysis vs Fundamental Analysis
Buy
64
LivaNova PLC (LIVN)
is a Buy
Is LivaNova PLC a Buy or a Sell?
-
LivaNova PLC stock is rated a BuyThe current LivaNova PLC [LIVN] share price is $46.30. The Score for LIVN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.